Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight
| Class:Id | LiteratureReference:9728525 |
|---|---|
| _displayName | Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight |
| _timestamp | 2021-04-21 10:11:11 |
| author | [Person:5228432] Zhang, L [Person:8877541] Feng, Y [Person:9728547] List, J [Person:9728494] Kasichayanula, S [Person:9728526] Pfister, M |
| created | [InstanceEdit:9728508] Jassal, Bijay, 2021-04-21 |
| journal | Diabetes Obes Metab |
| pages | 510-6 |
| pubMedIdentifier | 20518806 |
| title | Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight |
| volume | 12 |
| year | 2010 |
| (literatureReference) | [Summation:9728530] The human gene SLC5A2 encodes sodium/glucose cotransporter 2... [ChemicalDrug:9728168] dapagliflozin [extracellular region] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight (9728525)
